All In Biotech

Free tool

FAERS Monitor: Lunesta

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021476 or its brand name (Lunesta, Eszopiclone). Reports on generic versions are filed under their own applications.

Reports

25,514

Serious

10,237

40% of reports

Hospitalization

4,715

Death reported

1,692

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,890
  • insomnia3,913
  • dysgeusia3,855
  • nausea1,428
  • fatigue1,239
  • middle insomnia1,217
  • headache1,193
  • dizziness899
  • somnolence895
  • anxiety868
  • initial insomnia857
  • pain835
  • diarrhoea792
  • depression728
  • fall681

Reports by year received

View as table
YearReports
20052,348
20064,423
20072,929
2008481
2009527
2010726
2011547
2012718
2013654
2014659
20151,010
20161,374
20171,123
20181,232
20191,148
20201,041
2021782
2022823
2023737
2024827
2025821
2026584

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,645 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
initial insomniaSignal85775.070.057,336
middle insomniaSignal1,21757.454.263,061
dysgeusiaSignal3,85545.143.7157,990
insomniaSignal3,91312.311.940,437
somnolenceSignal8953.73.41,750
drug ineffectiveSignal4,8903.13.07,235
depressionSignal7282.62.5748
anxietySignal8682.52.4802
fall6811.71.6193
headache1,1931.61.5253
nausea1,4281.51.4237
dizziness8991.51.4146
fatigue1,2391.31.295
pain8351.11.011
diarrhoea7921.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.